Nigeria is expected to receive 176,000 doses of the Johnson and Johnson COVID-19 vaccines on Wednesday.
Executive Director, National Primary Health Care Development Agency, Faisal Shuaib, confirmed this at a news conference in Abuja on Tuesday.
He said the J&J vaccine, like the AstraZeneca, is safe and efficient against the coronavirus disease, including the deadlier Delta variant.
The J&J vaccine is a single-shot vaccine.
It is expected to boost Nigeria’s COVID-19 fight with the Delta variant sparking fears of a third wave of the pandemic.
More than 200 million cases of the pandemic have been confirmed globally, with the death toll reaching four million.
Supreme Court Invalidates National Lottery Act, Restricts Enforcement To FCT
House Of Reps Rejects Six-Year Single Term Bill For President, Governors
Senate Approves ₦1.77 Trillion Loan Request By President Tinubu
Finland Arrests Pro-Biafran Agitator Simon Ekpa On Terror Charges